| # | Drug | Count |
|---|---|---|
| 0 | AZACITIDINE | 90 |
| 1 | CYCLOPHOSPHAMIDE | 66 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 66 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 66 |
| 4 | PREDNISONE | 56 |
| 5 | METHOTREXATE SODIUM | 41 |
| 6 | LENALIDOMIDE | 39 |
| 7 | AZACITIDINE FOR | 36 |
| 8 | METHOTREXATE | 36 |
| 9 | MYCOPHENOLATE MOFETIL | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEDAZURIDINE AND DECITABINE | 3 | 0.0031 |
| 1 | AZACITIDINE | 90 | 0.0030 |
| 2 | DECITABINE | 11 | 0.0025 |
| 3 | MECASERMIN | 2 | 0.0025 |
| 4 | LISOCABTAGENE MARALEUCEL | 2 | 0.0023 |
| 5 | IBRITUMOMAB TIUXETAN | 3 | 0.0020 |
| 6 | LOMUSTINE | 5 | 0.0019 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 7 | 0.0015 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 9 | 0.0014 |
| 9 | ROMIPLOSTIM | 21 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 131 |
| 1 | Corticosteroid [EPC] | 114 |
| 2 | Alkylating Drug [EPC] | 76 |
| 3 | Kinase Inhibitor [EPC] | 59 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 46 |
| 5 | Thalidomide Analog [EPC] | 44 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 36 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 30 |
| 9 | Platinum-based Drug [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 21 | 0.0014 |
| 2 | Actinomycin [EPC] | 2 | 0.0009 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 4 | Sulfone [EPC] | 7 | 0.0006 |
| 5 | Pyrethroid [EPC] | 1 | 0.0006 |
| 6 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 131 | 0.0005 |
| 9 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |